MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Biogen Company Profile (NASDAQ:BIIB)

Consensus Ratings for Biogen (NASDAQ:BIIB) (?)
Ratings Breakdown: 8 Hold Rating(s), 14 Buy Rating(s)
Consensus Rating:Buy (Score: 2.64)
Consensus Price Target: $429.37 (41.01% upside)

Current Analysts' Coverage Summary for Biogen (NASDAQ:BIIB)
Show:
DateFirmActionRatingPrice TargetActions
8/25/2015Cowen and CompanyReiterated RatingBuy$494.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2015HC WainwrightReiterated RatingBuy$380.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015JPMorgan Chase & Co.Reiterated RatingBuy$414.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015Sanford C. BernsteinUpgradeMarket Perform -> Outperform$436.00 -> $385.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015ArgusLower Price TargetBuy$450.00 -> $360.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015RBC CapitalReiterated RatingOutperform$525.00 -> $450.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015Robert W. BairdDowngradeOutperform -> Neutral$480.00 -> $316.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015Morgan StanleyReiterated RatingOverweight$520.00 -> $426.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$511.00 -> $360.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2015Leerink SwannReiterated RatingBuy$512.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2015Piper JaffrayDowngradeOverweight -> Neutral$485.00 -> $410.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2015Goldman SachsBoost Price TargetNeutral$434.00 -> $435.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015Bank of AmericaUpgradeNeutral -> Buy$391.23 -> $466.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015GuggenheimInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015NomuraReiterated RatingNeutral$401.00 -> $442.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Citigroup Inc.Lower Price TargetBuy$512.00 -> $497.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015OppenheimerInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2015BarclaysReiterated RatingOverweight$500.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Stifel NicolausDowngradeBuy -> Hold$451.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Credit SuisseReiterated RatingOutperform$400.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2014S&P Equity ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2014Jefferies GroupReiterated RatingBuy$380.00 -> $410.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2014Brean CapitalBoost Price TargetBuy$293.00 -> $377.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2014Canaccord GenuityBoost Price TargetBuy$291.00 -> $355.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2013FBR & Co.UpgradeUnderperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013Wells Fargo & Co.Reiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/27/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha